Lurbinectedin Maintenance in SCLC: Insights from the IMforte Trial – Targeted Oncology March 9, 2026 by live-feeds Lurbinectedin Maintenance in SCLC: Insights from the IMforte Trial Targeted Oncology Source link Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Related Related posts: J. Valančiūnas Signs with the Wizards: A Lithuanian Stunner Joins the Team The medical entrance exam is over – Antibiotics vs. Appendectomy for Imaging-Confirmed Acute Appendicitis in Adults – NEJM Journal Watch Comparing the Outcomes of Thrombus Aspiration Versus Standard Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention – Cureus